ARCHIVES

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 27 | July 4, 1980

Download PDF Visit The Full Archive

Related Articles

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992

NCI Separates Carcinogenesis Research Efforts

February 18, 1977

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994